[Influenza virus, human: two avenues for the new treatment].
Casselyn
Marina
M
D000911:Antibodies, Monoclonal / Q000276:immunology*; D030561:Databases, Nucleic Acid; D006389:Hemagglutinins, Viral / Q000276:immunology*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D007251:Influenza, Human / Q000201:enzymology / Q000276:immunology* / Q000628:therapy*; D009975:Orthomyxoviridae / Q000201:enzymology / Q000276:immunology*; D021122:Protein Subunits / Q000378:metabolism; D012315:RNA Caps / Q000378:metabolism; D012324:RNA-Dependent RNA Polymerase / Q000378:metabolism; D014764:Viral Proteins / Q000378:metabolism; D014779:Virus Replication / Q000276:immunology*
D000911:Antibodies, Monoclonal; D006389:Hemagglutinins, Viral; C061290:PA protein, influenza viruses; D021122:Protein Subunits; D012315:RNA Caps; D014764:Viral Proteins; D012324:RNA-Dependent RNA Polymerase